Best Priced Peptides in Bali • Highest Quality • Lab Tested

HOME › PEPTIDES ›

TOTAL PRICE IDR 3,500,000
ORDER NOW

Tesamorelin Pen 10mg

IDR 3,500,000
In Stock
PENS
Same Day Dispatch Secure
Order on WhatsApp
Lab Grade

Research Outcomes

  • Significant visceral adipose tissue reduction in clinical trials
  • Improved lipid profile markers
  • Raised IGF-1 levels through GHRH pathway
  • FDA-approved molecule in HIV-associated lipodystrophy research

*Effects observed in controlled research studies. Not medical advice.

Tesamorelin Pen 10mg

IDR 3,500,000
In Stock
PENS
Same Day Dispatch Secure
Order on WhatsApp
Direct lab-to-lab logistics coordination

COMPOUND OVERVIEW

Tesamorelin is a GHRH analog studied for visceral fat reduction, IGF-1 axis stimulation, and body composition, delivered in a prefilled pen for convenient once-daily evening protocols.
Category
Purity
Primary Research Areas
Visceral fat reduction, IGF-1 axis, body composition, metabolic health
Storage
Keep refrigerated (2 to 8C)
VIEW DOSAGE PROTOCOL

RESEARCH DISCLOSURE

This product is supplied for research purposes only and is not intended for human consumption.

Order via WhatsApp

Research Verification Required

Peptide+ logo

This website provides access to research-grade peptide compounds intended exclusively for in-vitro laboratory research and scientific study.

By entering this site, you confirm and acknowledge the following:

I am a qualified researcher, laboratory professional, or authorized purchaser acting on behalf of a research institution.
I accept full liability and responsibility for the handling, storage, and application of any compounds purchased.
I agree to comply with all local, national, and international regulations governing the purchase and use of research compounds in my jurisdiction.
I am at least 18 years of age (or the legal age of majority in my region).
I CONFIRM — ENTER SITE
I DO NOT AGREE — LEAVE SITE

By proceeding, you agree to our Terms of Service and acknowledge our Research Use Policy. peptide+ reserves the right to refuse service to any individual or entity suspected of misuse.